Page 856 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 856

Chapter 52  Histiocytic Disorders  739


              lymphohistiocytosis  and  not  as  X-linked  lymphoproliferative  disease.   Risma  K,  Jordan  MB:  Hemophagocytic  lymphohistiocytosis:  updates  and
              Blood 116:1079, 2010.                                 evolving concepts. Curr Opin Pediatr 24:9, 2012.
            Marsh  RA,  Vaughn  G,  Kim  MO,  et al:  Reduced-intensity  conditioning   Simko SJ, McClain KL, Allen CE: Up-front therapy for LCH: is it time to test
              significantly improves survival of patients with hemophagocytic lympho-  an alternative to vinblastine/prednisone? Br J Haematol 169(2):299–301,
              histiocytosis  undergoing  allogeneic  hematopoietic  cell  transplantation.   2015. doi: 10.1111/bjh.13208. [Epub 2014 Nov 16].
              Blood 116:5824, 2010.                               Simko SJ, Tran HD, Jones J, et al: Clofarabine salvage therapy in refractory
            Minkov  M:  Multisystem  Langerhans  cell  histiocytosis  in  children:  current   multifocal histiocytic disorders, including Langerhans cell histiocytosis,
              treatment and future directions. Paediatr Drugs 13:75, 2011.  juvenile  xanthogranuloma  and  Rosai-Dorfman  disease.  Pediatr  Blood
            Minkov M, Steiner M, Pötschger U, et al: International LCH Study Group:   Cancer 61(3):479–487, 2014. doi: 10.1002/pbc.24772. [Epub 2013 Sep
              reactivations  in  multisystem  Langerhans  cell  histiocytosis:  data  of  the   18].
              international LCH registry. J Pediatr 153:700, 705, e701-702, 2008.  Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al: Perforin gene defects in
            Nelson  DS,  Quispel W,  Badalian-Very  G,  et al:  Somatic  activating  ARAF   familial hemophagocytic lymphohistiocytosis. Science 286:1957, 1999.
              mutations  in  Langerhans  cell  histiocytosis.  Blood  123(20):3152–3155,   Trottestam H, Horne A, Aricò M, et al: Histiocyte Society: Chemoimmuno-
              2014.                                                 therapy for hemophagocytic lymphohistiocytosis: long-term results of the
            Phillips  M,  Allen  C,  Gerson  P,  et al:  Comparison  of  FDG-PET  scans  to   HLH-94 treatment protocol. Blood 118:4577, 2011.
              conventional radiography and bone scans in management of Langerhans   Weitzman S, Jaffe R: Uncommon histiocytic disorders: the non-Langerhans
              cell histiocytosis. Pediatr Blood Cancer 52:97, 2009.  cell histiocytoses. Pediatr Blood Cancer 45:256, 2005.
            Ravelli A, Grom AA, Behrens EM, et al: Macrophage activation syndrome   Zhang K, Jordan MB, Marsh RA, et al: Hypomorphic mutations in PRF1,
              as  part  of  systemic  juvenile  idiopathic  arthritis:  diagnosis,  genetics,   MUNC13-4, and STXBP2 are associated with adult-onset familial HLH.
              pathophysiology and treatment. Genes Immun 13:289, 2012.  Blood 118:5794, 2011.
            Rigaud S, Fondanèche MC, Lambert N, et al: XIAP deficiency in humans   zur Stadt U, Schmidt S, Kasper B, et al: Linkage of familial hemophagocytic
              causes  an  X-linked  lymphoproliferative  syndrome.  Nature  444:110,   lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identifica-
              2006.                                                 tion of mutations in syntaxin 11. Hum Mol Genet 14:827, 2005.
   851   852   853   854   855   856   857   858   859   860   861